Eyenovia Announces Share Sale for Corporate Development

Eyenovia (EYEN) has issued an update.

Eyenovia, Inc. has entered into an agreement to sell 12.85 million shares of its common stock at $0.40 per share, aiming to raise approximately $5.14 million. The proceeds are intended for product commercialization, clinical studies, working capital, and general corporate purposes, which may include repaying existing loans. The transaction, facilitated by Dawson James Securities, Inc. as the placement agent, is expected to close on August 22, 2024, with standard closing conditions.

For a thorough assessment of EYEN stock, go to TipRanks’ Stock Analysis page.